Maiva Pharma funding, investors and company details

Maiva Pharma is an emerging Healthcare - Hospitals and Clinic startup from Bengaluru, working in the space of Pharmaceutical Manufacturing (Sterile Injectables / Drug Formulation & Development).

Company: Maiva Pharma Private Limited
Sector: Healthcare - Hospitals and Clinic
Location: Bengaluru
Total funding raised: ₹1,000 Cr

Company overview

Maiva Pharma Private Limited is a pharmaceutical manufacturing company specializing in sterile liquid formulations, primarily delivered through glass-based packaging such as vials, ampoules, and large-volume bottles. Originally operating as Global Pharmatech , the company has built a strong foundation in the production of high-quality injectable and infusion products since its inception in 1996. The company’s core business lies in contract manufacturing and development of sterile pharmaceuticals for domestic and international markets. It caters to pharmaceutical companies by offering end-to-end solutions, including formulation development, manufacturing, packaging, and regulatory support. Its expertise in sterile manufacturing allows it to serve critical therapeutic segments where product quality, precision, and compliance are essential. Maiva Pharma operates advanced manufacturing facilities designed to meet stringent global regulatory standards such as GMP (Good Manufacturing Practices). This enables the company to supply products to regulated and semi-regulated markets, positioning it as a reliable partner for global pharma companies. A key strength of the business is its focus on injectables and hospital-based therapies, which are high-demand and high-entry-barrier segments in the pharmaceutical industry. By leveraging its technical capabilities and long-standing experience, the company ensures consistent product quality and scalability. Overall, Maiva Pharma’s business is centered on sterile pharmaceutical manufacturing, contract development, and global supply, making it an important player in the injectable drugs segment of the healthcare industry.

Funding rounds

Latest round: ₹1,000.00 Cr. ($ 119.88 Mn), 2024-05-03. Investors: Nirav Mehta (Morgan Stanley Private Equity), InvAscent